![Polymers | Free Full-Text | Purification of Colon Carcinoma Cells from Primary Colon Tumor Using a Filtration Method via Porous Polymeric Filters Polymers | Free Full-Text | Purification of Colon Carcinoma Cells from Primary Colon Tumor Using a Filtration Method via Porous Polymeric Filters](https://pub.mdpi-res.com/polymers/polymers-13-03411/article_deploy/html/images/polymers-13-03411-ag.png?1633956169)
Polymers | Free Full-Text | Purification of Colon Carcinoma Cells from Primary Colon Tumor Using a Filtration Method via Porous Polymeric Filters
![Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/821986/821986_Thumb_400.jpg)
Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
![Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen](https://cdnintech.com/media/chapter/46036/1512345123/media/fig1.png)
Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen
![The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/4/5/e004385/F6.large.jpg)
The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419347507-gr1.jpg)
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
![Surveillance testing for colorectal cancer: New evidence supports a change in guidelines | The Bulletin Surveillance testing for colorectal cancer: New evidence supports a change in guidelines | The Bulletin](http://bulletin.facs.org/wp-content/uploads/2018/12/acscrp_dec2018_table1.png)
Surveillance testing for colorectal cancer: New evidence supports a change in guidelines | The Bulletin
![PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/425728fadcea61776ea78a6e3ecbd2698e2a1f5d/4-Table3-1.png)
PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar
![Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis](https://www.frontiersin.org/files/Articles/821986/fonc-12-821986-HTML/image_m/fonc-12-821986-g001.jpg)
Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
![Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients | British Journal of Cancer Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2012.267/MediaObjects/41416_2012_Article_BFbjc2012267_Fig1_HTML.jpg)
Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients | British Journal of Cancer
![Rectal Cancer Workup: Laboratory Studies, Screening for Colon and Rectal Cancer, Histologic Findings Rectal Cancer Workup: Laboratory Studies, Screening for Colon and Rectal Cancer, Histologic Findings](https://img.medscapestatic.com/pi/meds/ckb/69/38369tn.jpg)
Rectal Cancer Workup: Laboratory Studies, Screening for Colon and Rectal Cancer, Histologic Findings
![A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-80785-1/MediaObjects/41598_2020_80785_Fig1_HTML.png)
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
![CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4997-y/MediaObjects/12885_2018_4997_Fig1_HTML.png)
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text
![Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2012.605/MediaObjects/41416_2013_Article_BFbjc2012605_Fig1_HTML.jpg)
Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer
![CEA levels and circulatory CEA clearance rates in colorectal cancer... | Download Scientific Diagram CEA levels and circulatory CEA clearance rates in colorectal cancer... | Download Scientific Diagram](https://www.researchgate.net/publication/12028873/figure/tbl1/AS:667705808007184@1536204878843/CEA-levels-and-circulatory-CEA-clearance-rates-in-colorectal-cancer-patients-Patients-2.png)